Publication | Closed Access

In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with β-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia

Burkholderia CepaciaAntimicrobial Drug DiscoveryAntimicrobial SusceptibilityAntibioticsMedicineBacterial PathogensPseudomonas AeruginosaAntimicrobial ChemotherapyMicrobiologyAntimicrobial PharmacokineticsInfection ControlAntimicrobial PharmacodynamicsPharmacologyAntimicrobial AgentsClinical MicrobiologyAntimicrobial ResistanceStenotrophomonas Maltophilia